New home care model for kidney disease tested – no dialysis needed
NCT ID NCT06411613
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a home-based conservative care program for veterans with advanced chronic kidney disease who chose not to start dialysis. The program involved a team of doctors, nurses, and other specialists providing care at home. Only 2 participants were enrolled before the study was terminated, so the main goal was to see if this approach was feasible and acceptable to patients and their caregivers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- conservative care program (home-based, multidisciplinary team)
- What this could lead to
- If successful, this model could offer a supportive, non-dialysis care option for people with advanced kidney disease, improving quality of life and aligning care with patient preferences.
- What could go wrong
- This was a very small pilot study (only 2 participants) that was terminated early, so results are limited. The approach may not work for everyone or in other healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
2 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Aug 2024
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients: * Receives primary +/- nephrology care from VAPS as defined as having at least 1 outpatient primary or nephrology visit in the prior year * Advanced CKD as defined as defined as having 2 or more outpatient measures of an eGFR 20 ml/min/1.73m2 separated by 90 or more days * Unsure or do not wish to undergo maintenance dialysis * Agreement by their VA primary +/- nephrology care provider that patients can participate in the study Caregivers: * Nominated by enrolled patient as a caregiver whom patient agrees to participate in the study Clinicians: * Employed at VAPS * Identified by enrolled Veterans as important to their CKD and nominated by the Veteran to be interviewed for the study Exclusion Criteria: Patients: * Unable to complete "teach-back" method of informed consent * Currently receiving maintenance dialysis * Currently enrolled in HBPC Program Caregivers: * Unable to complete "teach-back" method of informed consent * If a Veteran withdraws from the study, their caregivers' participation in the study is also terminated at that time Clinicians: * If a Veteran withdraws from the study, their clinicians will no longer be eligible to participate in interviews
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108-1532, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a food and friendship program slow kidney disease?
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Does better dialysis keep parathyroid hormone in check?
- Biobank aims to unlock the mysteries of calciphylaxis
- Do kidney patients know why a fistula matters before dialysis?